Long-Term Study Evaluating Rare Solid Tumors and Genetic Risks in Children and Adults Including Biospecimen Collection and Family Participation

What this Trial Is About

Researchers are studying rare solid tumors and hereditary cancer syndromes to better understand how these tumors develop and behave over time. This long-term observational study focuses on individuals with rare tumors, their family members, and carriers of genetic variants that increase the risk of rare tumors. The goal is to learn more about the natural history, clinical features, and genetic factors of these tumors, which could lead to improved screening, prevention, and treatment strategies. Participants may provide clinical information, family history, medical records, and biospecimens such as saliva, blood, urine, stool, and possibly tumor tissue. They may undergo physical exams, clinical photography, imaging scans using radiation or magnetic fields, genetic testing, and counseling. The study team will review these data and provide feedback. Participants may also be invited to attend rare tumor clinics, focus groups, or other related research protocols. Throughout the study, participants will be contacted annually to update medical and family history and report any changes in their tumors. Assessments include reviewing patient well-being and needs, specialist consultations, and various sample collections. The study aims to comprehensively track disease course and survival over ten years, offering insights to participants and the medical community while supporting ongoing monitoring and research collaboration.

Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors